AdvisorNet Financial, Inc - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 981 filers reported holding NOVARTIS A G in Q2 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
AdvisorNet Financial, Inc ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$6,112
-87.8%
60
-88.0%
0.00%
-75.0%
Q2 2023$50,253
+6.5%
498
-2.9%
0.00%0.0%
Q1 2023$47,196
+1.0%
513
-0.4%
0.00%
-20.0%
Q4 2022$46,721
-20.8%
515
-33.4%
0.01%
-16.7%
Q3 2022$59,000
-67.4%
773
-64.0%
0.01%
-66.7%
Q2 2022$181,000
+92.6%
2,146
+100.7%
0.02%
+200.0%
Q1 2022$94,000
+10.6%
1,069
+10.3%
0.01%
+20.0%
Q4 2021$85,000
+30.8%
969
+22.0%
0.01%0.0%
Q3 2021$65,000
-20.7%
794
-11.3%
0.01%0.0%
Q2 2021$82,000
+20.6%
895
+12.6%
0.01%0.0%
Q1 2021$68,000
-22.7%
795
-14.3%
0.01%
-28.6%
Q4 2020$88,000
+8.6%
928
-0.2%
0.01%0.0%
Q3 2020$81,000
-5.8%
930
-5.1%
0.01%0.0%
Q2 2020$86,000
-4.4%
980
-10.7%
0.01%
-12.5%
Q1 2020$90,000
-8.2%
1,097
+6.5%
0.01%0.0%
Q4 2019$98,000
+25.6%
1,030
+15.5%
0.01%
+14.3%
Q3 2019$78,000
+105.3%
892
+113.9%
0.01%
+75.0%
Q2 2019$38,000
-11.6%
417
-7.1%
0.00%
-20.0%
Q1 2019$43,000
+7.5%
449
-2.8%
0.01%
-16.7%
Q4 2018$40,000
-11.1%
462
-11.5%
0.01%0.0%
Q3 2018$45,000
-16.7%
522
-26.9%
0.01%
-14.3%
Q2 2018$54,000
-5.3%
714
+1.1%
0.01%
-12.5%
Q1 2018$57,000
+7.5%
706
+12.4%
0.01%0.0%
Q4 2017$53,0006280.01%
Other shareholders
NOVARTIS A G shareholders Q2 2018
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 332,962$27,452,0007.32%
Mawer Investment Management Ltd. 7,721,327$636,623,0005.86%
Martin Investment Management, LLC 133,246$10,986,0005.56%
SCHARF INVESTMENTS, LLC 1,330,175$109,673,0005.48%
Hansberger Growth Investors, LP 46,663$3,847,0005.19%
Bain Capital Public Equity Management II, LLC 440,233$36,297,0004.25%
First Fiduciary Investment Counsel, Inc. 187,633$15,470,0004.10%
GARLAND CAPITAL MANAGEMENT INC 53,555$4,416,0004.02%
Lowell Blake & Associates Inc. 37,219$3,069,0003.94%
PRENTISS SMITH & CO INC 68,027$5,609,0003.89%
View complete list of NOVARTIS A G shareholders